The efficacy of live attenuated and inactivated influenza vaccines in children as a function of time postvaccination

Pediatric Infectious Disease Journal

Volumn 29, Issue 9, 2010, Pages 806-811

  Ambrose, Christopher S ^a   Wu, Xionghua ^a   Belshe, Robert B ^b  

^a MEDIMMUNE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

children; efficacy; inactivated influenza vaccine; live influenza vaccine

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; IMMUNITY; INCIDENCE; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; UNITED STATES;

EID: 77955982245     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181e2872f     Document Type: Article

References (43)

1. Rhorer J, Ambrose CS, Dickinson S, et al. Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials. Vaccine. 2009;27:1101-1110.
2. Jefferson T, Rivetti A, Harnden A, et al. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2008;2:CD004879.
3. Negri E, Colombo C, Giordano L, et al. Influenza vaccine in healthy children: a meta-analysis. Vaccine. 2005;23:2851-2861.
4. Zangwill KM, Belshe RB. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J. 2004;23:189-197.
5. Ashkenazi S, Vertruyen A, Aristegui J, et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pedi-atr Infect Dis J. 2006;25:870-879.
6. Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007;356:685-696.
7. Fleming DM, Crovari P, Wahn U, et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J. 2006;25:860-869.
8. SDI. SDI reports: number of flu vaccines given in physicians' offices up 237% so far this year. Available at: http://www.sdihealth.com/about-us/releases/ FLU-PR9-2-09.pdf. Accessed December 18, 2009.
9. Bhatt P, Block SL, Ambrose CS. Real-time assessment of 2008-2009 influenza vaccine utilization among practicing pediatricians. In: Proceedings from the Pediatric Academic Societies' Annual Meeting; May 2-5, 2009; Baltimore, MD. Abstract 753221.
10. Rand CM, Szilagyi PG, Yoo BK, et al. Additional visit burden for universal influenza vaccination of US school-aged children and adolescents. Arch Pediatr Adolesc Med. 2008;162:1048-1055.
11. Judelsohn RG, Ambrose CS, McLaurin KK, et al. Impact of early and late influenza vaccine availability on in-office vaccination opportunities. Paper presented at: 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/46th Annual Meeting of the Infectious Diseases Society of America; 2008; Washington, DC. Abstract G1-1208.
12. Jackson LA, Neuzil KM, Baggs J, et al. Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study. Pediatrics. 2006;118:2032-2037.
13. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009; 58:1-52.
14. American Academy of Pediatrics. Recommendations for prevention and control of influenza in children, 2009-2010. Available at http://aapredbook. aappublications.org/news/FluPolicy2009-10.pdf. Accessed December 3, 2009.
15. Centers for Disease Control and Prevention. Live, intranasal influenza vaccine: what you need to know, 2009-2010. Available at: http://www.cdc. gov/vaccines/pubs/vis/default.htm#flu. Accessed December 3, 2009.
16. Centers for Disease Control and Prevention. Inactivated influenza vaccine: whatyouneedtoknow,2009-2010.Availableat:http://www.cdc.gov/vaccines/ pubs/vis/default.htm#flu. Accessed December 3, 2009.
17. Ambrose CS, Yi T, Walker RE, et al. Duration of protection provided by live attenuated influenza vaccine in children. Pediatr Infect Dis J. 2008;27: 744-748.
18. Tam JS, Capeding MR, Lum LC, et al. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J. 2007;26: 619-628.
19. Gaglani MJ, Piedra PA, Herschler GB, et al. Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. Arch Pediatr Adolesc Med. 2004;158:65-73.
20. Bracco Neto H, Farhat CK, Tregnaghi MW, et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Pediatr Infect Dis J. 2009;28:365-371.
21. Wright PF, Sannella E, Shi JR, et al. Antibody responses after inactivated influenza vaccine in young children. Pediatr Infect Dis J. 2008;27:1004-1008.
22. Noble GR, Kaye HS, O'Brien RJ, et al. Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination. Dev Biol Stand. 1977;39:253-260.
23. Lerman SJ, Wright PF, Patil KD. Antibody decline in children following A/New Jersey/76 influenza virus immunization. J Pediatr. 1980;96:271-274.
24. Johnson PR Jr, Feldman S, Thompson JM, et al. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J Med Virol. 1985;17:325-335.
25. Johnson PR, Feldman S, Thompson JM, et al. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis. 1986;154: 121-127.
26. Belshe RB, Ambrose CA, Walker RE, et al. Genetic sequences of circulating 2004-2005 influenza strains and serum antibody responses to LAIV vs. TIV in young children. Paper presented at: Joint Meeting of the Pediatric Academic Societies and Asian Society for Pediatric Research; May 2-6, 2008; Honolulu, HI.
27. Belshe RB, Coelingh K, Ambrose CS, et al. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine. 2010;28:2149-2156.
28. Zuccotti G, Amendola A, Vigano A, et al. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma. Vaccine. 2007;25:6692-6698.
29. Belshe RB, Gruber WC, Mendelman PM, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr. 2000;136:168-175.
30. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics. 2007;120:e553-e564.
31. Ritzwoller DP, Bridges CB, Shetterly S, et al. Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics. 2005;116:153-159.
32. Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis. 2009;199: 159-167.
33. Skowronski DM, De Serres G, Dickinson J, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis. 2009;199:168-179.
34. Hawksworth AW, Russell KL, Faix DJ, et al. Effectiveness of the 2006-2007 influenza vaccine: data from US military basic training centers. In: Proceedings from the 6th Meeting of the Options for Control of Influenza Diseases; June 17-23, 2007; Toronto, ON, Canada. Abstract P725.
35. Hawksworth AW, Russell KL, Strickler JK, et al. Effectiveness of the 2004-2005 influenza vaccine: data from US military basic training centers. In: Proceedings from the 43rd Annual Meeting of IDSA; October 6-9, 2005; San Francisco, CA. Abstract 1012.
36. Treanor JJ, Kotloff K, Betts RF, et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine. 1999; 18:899-906.
37. Ohmit SE, Victor JC, Rotthoff JR, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med. 2006;355:2513-2522.
38. Strickler JK, Hawksworth AW, Myers C, et al. Influenza vaccine effectiveness among US military basic trainees, 2005-2006 season. Emerg Infect Dis. 2007;13:617-619.
39. Monto AS, Ohmit SE, Petrie JG, et al. Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med. 2009;361: 1260-1267.
40. Wang Z, Tobler S, Roayaei J, et al. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel. JAMA. 2009;301:945-953.
41. Eick AA, Wang Z, Hughes H, et al. Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members. Vaccine. 2009;27:3568-3575.
42. Skowronski DM, Tweed SA, De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J Infect Dis. 2008;197:490-502.
43. Clark A, Potter CW, Jennings R, et al. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity. J Hyg (Lond). 1983;90:361-370.